Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Itron Inc. filings document the reporting, governance and capital-structure records of an operating company serving utility and city infrastructure markets. Recent 8-K disclosures cover operating results, financial-condition updates, material agreements and the issuance of convertible senior notes, including purchase agreement and indenture terms tied to the company’s debt and equity structure.
Proxy and shareholder-vote filings describe director elections, advisory executive-compensation votes and annual meeting matters for holders of Itron common stock. Other material-event filings record cybersecurity response and operational-continuity disclosures, while exchange-registration information identifies ITRI common stock, no par value, as listed on the Nasdaq Global Select Market.
Itron, Inc. executive Laurie Ann Pulatie-Hahn, SVP of Human Resources, reported an open-market sale of company common stock. On 02/11/2026, she sold 142 shares of Itron common stock at $105.2648 per share. According to the filing, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, which is a common administrative transaction rather than a discretionary sale. After this transaction, she beneficially owned 21,783 shares of Itron common stock directly.
Laurie A. Hahn filed a notice of proposed sale of 142 shares of common stock under Rule 144, to be sold through Fidelity Brokerage Services LLC on February 11, 2026 on NASDAQ, with an aggregate market value of $14,947.60.
The 142 shares were acquired on February 10, 2026 via restricted stock vesting from the issuer as compensation. The notice also reports prior sales of 76 shares for $7,683.22 on November 11, 2025 and 108 shares for $10,422.66 on November 24, 2025.
Itron, Inc. director stock activity: A member of Itron's board of directors reported receiving a grant of 220 shares of common stock on 01/02/2026 as part of the quarterly compensation that independent directors receive for board service. The shares were reported at a price of $0, reflecting that they were granted, not purchased in the market. Following this grant, the director beneficially owned 15,773 shares directly.
The filing notes that the director, Mr. Leyden, deferred receipt of 82 of these shares under Itron's Executive Deferred Compensation Plan. The amendment also corrects an earlier arithmetic error by adding 9 shares that were inadvertently omitted in a prior report.
Itron, Inc. reported an amended insider filing showing a routine equity grant to a board member. On 01/02/2026, an independent director, Mr. Drury, was granted 555 shares of Itron common stock at a stated price of $0 as part of the quarterly stock compensation that independent members of the board receive for their service. After this grant, he beneficially owned 1,143 common shares in direct form.
The filing explains that Mr. Drury deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the shares are credited but delivery is postponed according to the plan’s terms. The amendment clarifies that 26 shares were previously omitted due to an arithmetic error, and are now included in the reported ownership figure.
Itron, Inc. reported an amended insider filing for a board member. On 01/02/2026, an independent director received a grant of 555 shares of Itron common stock as part of the quarterly equity compensation that independent members of the board receive for their service. The shares were granted at a stated price of $0, reflecting that this was board compensation rather than an open‑market purchase.
Following this grant and the correction, the director beneficially owns 9,564 shares of Itron common stock. The amendment explains that 26 shares were previously omitted due to an arithmetic error and are now included in the reported holdings.
Itron, Inc. reported that one of its directors received a grant of 555 shares of common stock on 01/02/2026 as part of the quarterly equity compensation paid to independent board members. The shares were issued at a stated price of $0, reflecting a compensatory award rather than an open-market purchase.
The amended filing corrects a prior arithmetic error by adding 26 shares that were previously omitted. Following this correction and the reported grant, the director now beneficially owns 5,623 shares of Itron common stock in direct ownership.
Itron, Inc. reported an amended insider transaction for a board member. On 01/02/2026, the director received 555 shares of common stock at a stated price of $0, reflecting the quarterly stock grant that independent directors receive as part of their annual board compensation. Following this grant, the director beneficially owned 11,318 shares directly.
The amendment clarifies that the reported holdings now include an additional 26 shares that were previously omitted due to an arithmetic error, ensuring the ownership total is accurate.
Itron, Inc. reported an updated insider stock holding for one of its directors. On 01/02/2026, the director received a grant of 555 shares of common stock at a price of $0, representing the quarterly stock compensation that independent board members earn as part of their annual board service. Following this grant, the director beneficially owned 1,186 shares directly. The filing is an amendment to a prior Form 4 and clarifies that 26 shares had been inadvertently omitted earlier due to an arithmetic error.
Itron, Inc. reported an amended insider transaction for a board member on a Form 4/A. On 01/02/2026, an independent director received a grant of 555 shares of common stock as part of the quarterly stock compensation for serving on the board. The filing notes these shares were deferred under Itron's Executive Deferred Compensation Plan rather than received immediately. Following this grant, the director beneficially owned 21,917 Itron shares. The amendment clarifies that 26 shares had previously been omitted due to an arithmetic error.
Itron, Inc. (ITRI) reported an insider transaction by its VP, Corporate Controller & Chief Accounting Officer. On 11/24/2025, the officer sold 104 shares of common stock in a single transaction at a price of $96.5061 per share. After this transaction, the officer beneficially owns 7,581 shares directly.
According to the filing, the sale represents shares that were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award, rather than a discretionary open-market sale of the officer's overall holdings.